Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Head & Neck 2Gastrointestinal 2Other 1Gynecologic 1Endocrine 1Breast 1

Conditions

Breast Neoplasms 3863Motor Activity 228Neoplasms 201Prostatic Neoplasms 167Colorectal Neoplasms 146Lung Neoplasms 139Lymphedema 125Fatigue 104Ovarian Neoplasms 98Carcinoma, Intraductal, Noninfiltrating 94Colonic Neoplasms 86Breast Cancer Lymphedema 86Pain 81Breast Cancer Female 76Anxiety Disorders 76Uterine Cervical Neoplasms 73Depression 70Triple Negative Breast Neoplasms 66Breast Carcinoma In Situ 66Head and Neck Neoplasms 55Pain, Postoperative 54Obesity 54Neoplasm Metastasis 48Melanoma 42Endometrial Neoplasms 39Pancreatic Neoplasms 38Lymphoma 38Carcinoma, Non-Small-Cell Lung 34Sleep Initiation and Maintenance Disorders 33Sarcoma 33

Interventions

Tamoxifen 1Goserelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hyperlipidemias × Breast × Clear all
NCT00827307 2011-08-08

Zoladex Plus Tamoxifen in Breast Cancer

Zhejiang Cancer Hospital

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms, Hyperlipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡